Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2019

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #966

    Merck withdrew this Keytruda/Dara trial. Never started it actually. https://clinicaltrials.gov/ct2/history/NCT03221634?A=1&B=2&C=merged

    1 Reply Last reply
    0
    • B Offline
      B Offline
      Bella1
      wrote on sidst redigeret af
      #967

      Trump har sejret over de korrupte "Demokrater". En kommende (og forventet) recession er HELLER ikke hans skyld, og efter den, peger USA*s pil fortsat på fremdrift på alle parametre. - Dommedag er udskudt, til gavn og glæde for de fleste......:-)

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JKY_VH
        wrote on sidst redigeret af
        #968

        ? og god morgen:-)

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #969

          Just a moment...

          favicon

          (www.firstwordpharma.com)

          1 Reply Last reply
          0
          • P Offline
            P Offline
            Parasitism
            wrote on sidst redigeret af
            #970

            God morgen 🙂

            1 Reply Last reply
            0
            • J Offline
              J Offline
              JohnW
              wrote on sidst redigeret af
              #971

              Investtech: Genmab har brudt op gennem loftet i en faldende trendkanal på mellemlang sigt. Dette indikerer i første omgang svagere faldende takt, eller indledning til en mere horisontal udvikling. Aktien gav købssignal fra en omvendt-hovede-og-skuldre-formation ved bruddet op gennem modstanden ved 1103. Videre stigning til 1571 eller mere er signaleret. Aktien nærmer sig støtten ved cirka 1110 kroner, noget der kan give en reaktion op. Aktien anses samlet set teknisk positiv på mellemlang sigt.

              1 Reply Last reply
              0
              • J Offline
                J Offline
                JohnW
                wrote on sidst redigeret af
                #972

                Anbefaling: Køb

                1 Reply Last reply
                0
                • T Offline
                  T Offline
                  transalp
                  wrote on sidst redigeret af
                  #973

                  Go morgen 🙂

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    lahn1
                    wrote on sidst redigeret af
                    #974

                    07:11 - godt de har styr på det

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      Jazzz
                      wrote on sidst redigeret af
                      #975

                      Ikke en hel skidt dag at have NOVO, Genmab og Zealand aktier..

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        JKY_VH
                        wrote on sidst redigeret af
                        #976

                        Jep, det er bedre end B&O

                        1 Reply Last reply
                        0
                        • H Offline
                          H Offline
                          HTH
                          wrote on sidst redigeret af
                          #977

                          Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #978

                            Tilsyneladende ikke RTOR for Cass.

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #979

                              Nu er det også en kombination der bruges i Europa, så heller ikke forventet at få RTOR på den

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #980

                                great. let's hope european application can follow soon so we can get to the transplant eligible patients

                                1 Reply Last reply
                                0
                                • T Offline
                                  T Offline
                                  transalp
                                  wrote on sidst redigeret af
                                  #981

                                  Go morgen.. 🙂

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #982

                                    Novatis Mayzent : https://www.reuters.com/article/us-fda-mayzent/novartis-gets-u-s-approval-for-new-drug-to-treat-multiple-sclerosis-idUSKCN1R8019

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #983

                                      Link Preview Image
                                      Novartis receives FDA approval for Mayzent® (siponimod), the first oral drug to treat secondary progressive MS with active disease

                                      favicon

                                      Novartis (www.novartis.com)

                                      1 Reply Last reply
                                      0
                                      • B Offline
                                        B Offline
                                        bibob
                                        wrote on sidst redigeret af
                                        #984

                                        Også Celgene i MS. Der er kamp om det. https://m.firstwordpharma.com/hot-heels-eu-application-celgene-files-us-clearance-ozanimod-relapsing-multiple-sclerosis

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          Parasitism
                                          wrote on sidst redigeret af
                                          #985

                                          God morgen 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger